Bristol-Myers Squibb Postpones April 2, 2020 Investor Day

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) today announced that due to the ongoing COVID-19 pandemic, it will reschedule its planned April 2, 2020 Investor Day for a later date. The company will continue to assess the situation and follow guidance from local and global health authorities to determine the new date.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200323005105/en/

Bristol-Myers Squibb
Media:
[email protected]
609-252-3345

Investors:
Tim Power, 609-252-7509, [email protected]
Nina Goworek, 908-673-9711, [email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• Halliburton Announces Dividend
• The Games DEA Attorneys Play: What Marijuana Rescheduling Closing Brief Didn't Tell Judge Julius
• Genye Technology Opens New LA-Area Branch and Technology Demonstration Center in Southern California